Thomas D'Alonzo
Keine laufenden Positionen mehr
Profil
Thomas W.
D'Alonzo served as President and Chief Operating Officer at Pharmaceutical Product Development LLC from 1996 to 1999.
He was also President of Glaxo, Inc. from 1983 to 1993.
D'Alonzo held various director positions at BioDelivery Sciences International, Inc., DARA BioSciences, Inc., and BioDelivery Sciences International, Inc. from 2006 to 2018.
He was also Chairman and Chief Executive Officer at Salix Pharmaceuticals Ltd.
from 2015 to 2015 and President and Chief Executive Officer at GenVec, Inc. from 1993 to 1996.
Additionally, D'Alonzo served as Chief Executive Officer and Director at MiMedx Group, Inc. from 2008 to 2009 and Chairman at Plexigen, Inc. in 2010.
He received his undergraduate degree from the University of Delaware in 1965 and his graduate degree from Sturm College of Law.
Ehemalige bekannte Positionen von Thomas D'Alonzo
| Unternehmen | Position | Ende |
|---|---|---|
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Direktor/Vorstandsmitglied | 21.05.2018 |
| SALIX PHARMACEUTICALS, LTD. | Vorstandsvorsitzender | 01.04.2015 |
| MIMEDX GROUP, INC. | Vorstandsvorsitzender | 24.02.2009 |
| DARA BIOSCIENCES INC | Direktor/Vorstandsmitglied | 01.12.2008 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Direktor/Vorstandsmitglied | 04.06.2008 |
Ausbildung von Thomas D'Alonzo
| University of Delaware | Undergraduate Degree |
| Sturm College of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MIMEDX GROUP, INC. | Health Technology |
| Private Unternehmen | 9 |
|---|---|
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
Salix Pharmaceuticals Ltd.
 Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Salix Pharmaceuticals Ltd. develops and commercializes prescription drugs and medical devices used in the treatment of gastrointestinal diseases, endocrinology, hepatology, colorectal surgery, and internal medicine. It offers Anusol, Apriso, Colazal, Deflux, Diuril, Fenoglide, MoviPrep, Pepcid, Solesta, and Zegerid. The company was founded by randy W. Hamilton and Lorin K. Johnson in1989 and is headquartered in Bridgewater, NJ. | Health Technology |
Pharmaceutical Product Development LLC
 Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
Amarillo Biosciences, Inc.
 Amarillo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Amarillo Biosciences, Inc. engages in the discovery and development of pharmaceutical and biotech products. It operates through the following divisions: Pharmaceutical, Medical and Consumer. The company was founded by Joseph M. Cummins in June 1984 and is headquartered in Amarillo, TX. | Health Technology |
Plexigen, Inc.
 Plexigen, Inc. Miscellaneous Commercial ServicesCommercial Services Plexigen, Inc. provided diagnostic equipment. The company was founded by Ben Hui Liu and is headquartered in Cary, NC. | Commercial Services |
| Alynx Co. | Finance |
| Glaxo, Inc. | |
DARA BioSciences, Inc.
 DARA BioSciences, Inc. Pharmaceuticals: MajorHealth Technology DARA BioSciences, Inc. is a pharmaceutical company focused on the development and commercialization of oncology treatment and supportive care products. The company's product portfolio includes Soltamox, Gelclair, Bionect and KRN5500. Soltamox offers a choice to patients who prefer or need a liquid form of tamoxifen. Gelclair is an alcohol-free bioadherent oral rinse gel for rapid and effective relief of pain associated with oral mucositis caused by chemotherapy and radiation treatment. The company markets Bionect, a topical treatment for skin irritation and burns associated with radiation therapy, in U.S. oncology/radiology markets. DARA BioSciences was founded by Steven Gorlin on June 22, 2002 and is headquartered in Raleigh, NC. | Health Technology |
